Close Menu

NEW YORK (360Dx) – A massive beat of analyst expectations by Exact Sciences and a reworked agreement that signaled Abbott's intention to complete its acquisition of Alere catapulted Exact and Alere to the top of the gainers list month over month in the 360Dx Index.

Meanwhile, NantHealth's shares continued to feel the fallout from a story published nearly two months ago, alleging a questionable donation by the company's founder, and it repeated as the index's steepest decliner.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.